Deciphering hematological malignancies for improved disease management

SOPHiA Myeloid Solution  is a CE-IVD marked molecular diagnostic application that bundles a capture-based target enrichment kit with the analytical power of SOPHiA™ AI and full access to SOPHiA DDM® platform.

The solution was designed to accurately characterize the complex mutational landscape of major hematological disorders such as myelodysplastic syndromes, myeloproliferative neoplasms, and leukemia.

Benefits of the solution

Comprehensive

Detection of all types of genomic alterations (i.e SNVs, Indels and CNVs) in all the genes of the panel associated with hematological disorders

Accurate

Proven clinical-grade analytical performance 

Robust

Excellent coverage uniformity in all the genes of the panel, unlocking unmatched detection of complex variants in genes such as CEBPA, FLT3, ASXL1 and CALR

Flexible

Compatible with market-leading sequencing platforms without impact on performance. The gene panel can also be adapted according to experts' needs

 

1: MDS: myelodysplastic syndromes

2: MPN: myeloproliferative neoplasms